SLU-PP-322 is a research peptide investigated for its potential role in enhancing cellular energy regulation by targeting metabolic pathways. Early studies suggest it may help support mitochondrial efficiency and metabolism, but it remains strictly experimental and not approved for clinical use.

Key Benefits

•Increased fat burning

•Higher energy expenditure

•Improved thermogenesis

Science

•Increases UCP-1 & UCP-3 expression

•Acts as a mitochondrial uncoupler

•Enhances fatty-acid oxidation

Dosing

•No human data

Cycle Length

•Research only

Vials Needed

•Depends entirely on research model